Estudos de absorção de CO2 com soluções aminadas

A absorção química de dióxido de carbono (CO2) através de soluções aquosas de aminas tem sido estudada nos últimos anos devido à preocupação ambiental face ao aquecimento global. Nestes estudos, foram tidos como principais objectivos a realização de ensaios preliminares de absorção e desabsorção de CO2 em soluções aquosas de aminas bem como a construção de uma instalação piloto para a mesma finalidade. Inicialmente, a nível laboratorial, procedeu-se à absorção de CO2 através de soluções aquosas de aminas. As aminas utilizadas nestes estudos foram a monoetanolamina (MEA), etilenodiamina (EDA), 1,6- hexanodiamina (HDA) e piperazina anidra (PZ). A absorção de CO2 através destas aminas foi realizada experimentalmente às condições normais de pressão e temperatura. A concentração das soluções aquosas foi de 20% em massa de cada amina. Foram também realizados estudos de regeneração das soluções aquosas de aminas saturadas de CO2 em banho de glicerina, para determinar as condições de regeneração. Para além disso, observou-se o estado físico das aminas no estado puro até saturação com CO2 para garantir a não ocorrência de danos a nível de entupimento numa posterior utilização na instalação piloto. Por fim, voltaram-se a repetir todos estes ensaios experimentais utilizando-se, em vez da água destilada, um solvente polar aprótico, dimetilsulfóxido (DMSO). Numa segunda fase destes estudos, a absorção de CO2 através de soluções aquosas de aminas foi investigada experimentalmente numa instalação piloto. O objectivo era utilizar nesta fase do estudo as mesmas aminas utilizadas nos ensaios preliminares mas uma vez que não se dispunha das quantidades necessárias de aminas e para a sua aquisição teria que se despender bastante tempo e dinheiro, utilizaram-se duas soluções aquosas de alcanolaminas. As alcanolaminas utilizadas no presente estudo foram a amina secundária dietanolamina (DEA) e a amina terciária N-metildietanolamina (MDEA), duas aminas amplamente utilizadas nas indústrias químicas e petroquímicas para a purificação dos gases de combustão. A absorção de CO2 através destas duas alcanolaminas foi realizada experimentalmente às condições normais de pressão e temperatura. As concentrações das soluções aquosas foram de (10, 20 e 30) % em massa de MDEA e de DEA. O processo de adição de cloreto de bário (BaCl2.2H2O) às alcanolaminas ajuda à formação de carbonato de bário, quando o CO2 passa através da solução de alcanolamina. A quantidade de carbonato de bário formado foi utilizado para determinar a solubilidade do CO2 (mol CO2/mol alcanolamina). O principal desafio na captura de CO2 dos gases de combustão é o de reduzir o consumo de energia necessária para a regeneração do solvente. Deste modo, foram também realizados estudos de regeneração das soluções de alcanolaminas saturadas, para determinar as condições de regeneração. Os resultados obtidos, a nível laboratorial, revelaram que uma amina secundária (PZ) e uma amina primária de cadeia longa (HDA) são mais favoráveis ao processo de absorção e regeneração de CO2. No entanto, e devido a essa mesma estrutura molecular, necessitam de maiores valores de temperaturas para desabsorver o CO2. Garantiu-se poder trabalhar com as quatro aminas no estado puro em estudos futuros, na instalação piloto, garantindo que não ocorrerão danos a nível de entupimento. Relativamente ao solvente utilizado concluiu-se que um solvente polar aprótico não é um solvente favorável para estes estudos. Os resultados obtidos, na instalação piloto, revelaram que a amina terciária, MDEA, consegue absorver maiores quantidades de CO2 do que a amina secundária, EDA, bem como é a mais fácil de regenerar com menor perda de capacidade de absorção do que a EDA.

Valorização das águas corticeiras: extracção de antioxidantes

Dissertação para obtenção do Grau de Mestre em Engenharia Química e Bioquímica

Generation and characterization of function-blocking anti-ectodysplasin A (EDA) monoclonal antibodies that induce ectodermal dysplasia.

Development of ectodermal appendages, such as hair, teeth, sweat glands, sebaceous glands, and mammary glands, requires the action of the TNF family ligand ectodysplasin A (EDA). Mutations of the X-linked EDA gene cause reduction or absence of many ectodermal appendages and have been identified as a cause of ectodermal dysplasia in humans, mice, dogs, and cattle. We have generated blocking antibodies, raised in Eda-deficient mice, against the conserved, receptor-binding domain of EDA. These antibodies recognize epitopes overlapping the receptor-binding site and prevent EDA from binding and activating EDAR at close to stoichiometric ratios in in vitro binding and activity assays. The antibodies block EDA1 and EDA2 of both mammalian and avian origin and, in vivo, suppress the ability of recombinant Fc-EDA1 to rescue ectodermal dysplasia in Eda-deficient Tabby mice. Moreover, administration of EDA blocking antibodies to pregnant wild type mice induced in developing wild type fetuses a marked and permanent ectodermal dysplasia. These function-blocking anti-EDA antibodies with wide cross-species reactivity will enable study of the developmental and postdevelopmental roles of EDA in a variety of organisms and open the route to therapeutic intervention in conditions in which EDA may be implicated.

NF-kappaB transmits Eda A1/EdaR signalling to activate Shh and cyclin D1 expression, and controls post-initiation hair placode down growth.

A novel function of NF-kappaB in the development of most ectodermal appendages, including two types of murine pelage hair follicles, was detected in a mouse model with suppressed NF-kappaB activity (c(IkappaBalphaDeltaN)). However, the developmental processes regulated by NF-kappaB in hair follicles has remained unknown. Furthermore, the similarity between the phenotypes of c(IkappaBADeltaN) mice and mice deficient in Eda A1 (tabby) or its receptor EdaR (downless) raised the issue of whether in vivo NF-kappaB regulates or is regulated by these novel TNF family members. We now demonstrate that epidermal NF-kappaB activity is first observed in placodes of primary guard hair follicles at day E14.5, and that in vivo NF-kappaB signalling is activated downstream of Eda A1 and EdaR. Importantly, ectopic signals which activate NF-kappaB can also stimulate guard hair placode formation, suggesting a crucial role for NF-kappaB in placode development. In downless and c(IkappaBalphaDeltaN) mice, placodes start to develop, but rapidly abort in the absence of EdaR/NF-kappaB signalling. We show that NF-kappaB activation is essential for induction of Shh and cyclin D1 expression and subsequent placode down growth. However, cyclin D1 induction appears to be indirectly regulated by NF-kappaB, probably via Shh and Wnt. The strongly decreased number of hair follicles observed in c(IkappaBalphaDeltaN) mice compared with tabby mice, indicates that additional signals, such as TROY, must regulate NF-kappaB activity in specific hair follicle subtypes.

Ectodysplasin A (EDA)-EDA receptor signalling and its pharmacological modulation

L'ectodysplasine Al (EDA1 ou EDA), un ligand de la famille du TNF, et son récepteur EDAR favorisent le développement des poils, des dents et de plusieurs types de glandes. Chez l'humain, une déficience en EDA cause une dysplasie ectodermique liée à l'X, caractérisée par la genèse défectueuse des phanères. Les souris Tabby, déficientes en Eda, présentent des symptômes similaires. Nous démontrons que les souris Tabby sont en moyenne 7% plus légères que les contrôles au moment du sevrage. Ce phénotype ne dépend pas du génotype des petits, mais exclusivement de celui de la mère, suggérant que l'absence d'EDA perturbe la fonction mammaire. La glande mammaire se développe en plusieurs étapes, principalement à la puberté et pendant la grossesse. Nous avons généré des anticorps pour activer ou inhiber la signalisation d'EDAR. Les anticorps agonistes corrigent le développement de souris ou de chiens déficients en EDA, alors que les antagonistes provoquent une dysplasie ectodermique chez les souris saines. L'exposition répétée de souris Tabby aux anticorps agonistes après le sevrage accroît la taille et la fonction des glandes sébacées, démonstration pharmacologique qu'EDA contrôle l'homéostasie de la glande sébacée adulte. Ces outils seront utiles pour étudier la fonction d'EDA aux diverses étapes du développement de la glande mammaire. Fc-EDAl, un stimulateur d'EDAR, est en phase d'évaluation clinique. Nous avons montré que les structures dépendantes d'EDA qui se forment à différentes étapes du développement répondent à l'action du Fc-EDAl dans des fenêtres temporelles étroites ou larges. De plus, certaines structures peuvent être induites plusieurs jours après le début naturel de leur formation. Alors que la plupart des structures se forment suite à un seul jour d'activation d'EDAR, d'autre demandent un temps de stimulation plus long. La formation des dents est régulée par des signaux activateurs et inhibiteurs. Une forte stimulation d'EDAR spécifiquement appliquée aux deux premières molaires induit des signaux négatifs qui avortent la formation de la troisième molaire, alors qu'une forte stimulation donnée à la troisième molaire la rend hypertrophique tout en induisant parfois une quatrième molaire jamais observée chez les souris de type sauvage ou Tabby. EDA est donc un activateur important de la formation dentaire. Pris dans leur ensemble, ces résultats ont des implications pour la thérapie des dysplasies ectodermiques. - The TNF family ligand Ectodysplasin Al (EDA1 or EDA) and its receptor ED AR regulate embryonic development of hair, teeth and several types of glands. In humans, EDA mutations cause X-linked hypohidrotic ectodermal dysplasia (XLHED), a condition characterized by defective development of skin appendages. £da-deficient (Tabby) mice suffer from similar defects. We observed that Tabby pups at weaning were on average 7% smaller than WT controls, a phenotype that was curiously not linked to the genotype of pups, but to that of mothers, suggesting decreased mammary gland function in the absence of EDA. Mammary glands develop in several steps, most of which are post-natal. We generated monoclonal antibodies to block or activate EDAR signaling. Agonist antibodies rescued developmental defects when administered timely in £cfo-deficient mice and dogs, whereas blocking antibodies induced ectodermal dysplasia in WT mice. Agonist antibodies administered after weaning in £da-deficient mice for several months markedly increased both size and function of sebaceous glands, providing the first demonstration that pharmacological activation of the EDAR pathway in adults can correct important aspects of the dry skin phenotype. This also highlights a role for EDA1 in the homeostasis of adult sebaceous glands. These tools will be useful to study the function of EDA 1 at different stages of mammary gland development. Another EDAR agonist, Fc-EDAl, is currently evaluated in clinical trials. We found that EDA 1-dependent structures forming at different time points during development can respond to Fc-EDAl during time response windows that are narrow or wide. Also, some structures can be triggered up to several days after their normal time of induction. While most structures could be rescued by a single day of EDAR signaling, others required longer exposure times to form. Tooth formation is regulated by activating and inhibitory signals that impact one on the other. When strong EDAR signals were specifically given to the first two molars, overwhelming inhibitory signals completely inhibited formation of the third molar. In contrast, strong signals specifically given to the third molar induced hypertrophy of the later with occasional appearance of a fourth molar never observed in WT or £da-deficient mice. This clearly positions EDA as an important activating signal in tooth formation. Taken together, these results have implications for the therapy of ectodermal dysplasias.

Edar/Eda interactions regulate enamel knot formation in tooth morphogenesis.

tabby and downless mutant mice have apparently identical defects in teeth, hair and sweat glands. Recently, genes responsible for these spontaneous mutations have been identified. downless (Dl) encodes Edar, a novel member of the tumour necrosis factor (TNF) receptor family, containing the characteristic extracellular cysteine rich fold, a single transmembrane region and a death homology domain close to the C terminus. tabby (Ta) encodes ectodysplasin-A (Eda) a type II membrane protein of the TNF ligand family containing an internal collagen-like domain. As predicted by the similarity in adult mutant phenotype and the structure of the proteins, we demonstrate that Eda and Edar specifically interact in vitro. We have compared the expression pattern of Dl and Ta in mouse development, taking the tooth as our model system, and find that they are not expressed in adjacent cells as would have been expected. Teeth develop by a well recorded series of epithelial-mesenchymal interactions, similar to those in hair follicle and sweat gland development, the structures found to be defective in tabby and downless mice. We have analysed the downless mutant teeth in detail, and have traced the defect in cusp morphology back to initial defects in the structure of the tooth enamel knot at E13. Significantly, the defect is distinct from that of the tabby mutant. In the tabby mutant, there is a recognisable but small enamel knot, whereas in the downless mutant the knot is absent, but enamel knot cells are organised into a different shape, the enamel rope, showing altered expression of signalling factors (Shh, Fgf4, Bmp4 and Wnt10b). By adding a soluble form of Edar to tooth germs, we were able to mimic the tabby enamel knot phenotype, demonstrating the involvement of endogenous Eda in tooth development. We could not, however, reproduce the downless phenotype, suggesting the existence of yet another ligand or receptor, or of ligand-independent activation mechanisms for Edar. Changes in the structure of the enamel knot signalling centre in downless tooth germs provide functional data directly linking the enamel knot with tooth cusp morphogenesis. We also show that the Lef1 pathway, thought to be involved in these mutants, functions independently in a parallel pathway.

Chou Guzele Bir Bakin ; Seuyle Ey Mitrib Nazende Eda / Munir Bey, chant [acc. instr.]

[Traditions. Asie. Turquie]

Actividad electrodermal (EDA), personalidad y stress

En el presente trabajo de investigación nos planteamos estudiar la actividad electrodérmica (EDA), tanto en su aspecto tónico (registro de niveles) como el fásico (registro de respuestas) de 10s sujetos sometidos a una situación estresante, por la amenaza de schock eléctrico y su posible correlación con sus rasgos de personalidad (en las dimensiones de neuroticismo y extraversión del EPQ-A) y la ansiedad medida por el M.A.S. de Taylor. Para el1o nos hemos propuesto recoger y valorar las posibles soluciones planteadas por diferentes autores (Freixa i Baqué, 1975, 1977; Ferrer y Colom, 1983) a los problemas procedimentales y técnicos que presentan los registros y la utilización de la EDA, para asegurar la comparabilidad de los datos, la estandarización de 10s registros y el nivel de significación que pueda atribuirse al registro posterior de la respuesta del sujeto.El resultado del mismo nos da a conocer las correlaciones significativas existente entre: neuroticismo y ansiedad, neuroticismo y respuestas al primer y segundo estimulo y finalmente entre ansiedad y respuesta al segundo estimulo.

Permanent correction of an inherited ectodermal dysplasia with recombinant EDA.

X-linked hypohidrotic ectodermal dysplasia (XLHED; OMIM 305100) is a genetic disorder characterized by absence or deficient function of hair, teeth and sweat glands. Affected children may experience life-threatening high fever resulting from reduced ability to sweat. Mice with the Tabby phenotype share many symptoms with human XLHED patients because both phenotypes are caused by mutations of the syntenic ectodysplasin A gene (Eda) on the X chromosome. Two main splice variants of Eda, encoding EDA1 and EDA2, engage the tumor necrosis factor (TNF) family receptors EDAR and XEDAR, respectively. The EDA1 protein, acting through EDAR, is essential for proper formation of skin appendages; the functions of EDA2 and XEDAR are not known. EDA1 must be proteolytically processed to a soluble form to be active. Here, we show that treatment of pregnant Tabby mice with a recombinant form of EDA1, engineered to cross the placental barrier, permanently rescues the Tabby phenotype in the offspring. Notably, sweat glands can also be induced by EDA1 after birth. This is the first example of a developmental genetic defect that can be permanently corrected by short-term treatment with a recombinant protein.

Ectodysplasin A (EDA) - EDA receptor signalling and its pharmacological modulation.

The TNF family ligand ectodysplasin A (EDA) regulates the induction, morphogenesis and/or maintenance of skin-derived structures such as teeth, hair, sweat glands and several other glands. Deficiencies in the EDA - EDA receptor (EDAR) signalling pathway cause hypohidrotic ectodermal dysplasia (HED). This syndrome is characterized by the absence or malformation of several skin-derived appendages resulting in hypotrychosis, hypodontia, heat-intolerance, dry skin and dry eyes, susceptibility to airways infections and crusting of various secretions. The EDA-EDAR system is an important effector of canonical Wnt signalling in developing skin appendages. It functions by stimulating NF-κB-mediated transcription of effectors or inhibitors of the Wnt, Sonic hedgehog (SHH), fibroblast growth factor (FGF) and transforming growth factor beta (TGFβ) pathways that regulate interactions within or between epithelial and mesenchymal cells and tissues. In animal models of Eda-deficiency, soluble EDAR agonists can precisely correct clinically relevant symptoms with low side effects even at high agonist doses, indicating that efficient negative feedback signals occur in treated tissues. Hijacking of the placental antibody transport system can help deliver active molecules to developing foetuses in a timely manner. EDAR agonists may serve to treat certain forms of ectodermal dysplasia.

Evaluación del desarrollo articulatorio (EDA) : prueba simplificada para jardines de infancia, guarderías y escuelas de Educación Infantil.

Prueba de Evaluación del Desarrollo Articulatorio (EDA) que constituye un instrumento con el que se puede hacer un seguimiento del habla infantil en los primeros años de vida y de escolaridad del niño y comprobar si el alumno necesita algún tipo de apoyo o de intervención para mejorar su desarrollo.

EDA : Experimentación Didáctica en el Aula : ESO y Bachillerato.

Resumen basado en el de la publicación

EDA : Experimentación Didáctica en el Aula : Primaria, ESO y Bachillerato.

EDA (Experimentación Didáctica en el Aula) es un proyecto que pretende ayudar a los profesores a incorporar las TIC (Tecnologías de la Información y la Comunicación) a su actividad en el aula, detectar las ventajas e inconvenientes de utilizar estas nuevas tecnologías y encontrar nuevos enfoques didácticos de enseñanza y aprendizaje. Contiene el resultado de la experimentación en el aula con los recursos interactivos de los proyectos Descartes, Newton y MALTED por parte de profesores de Matemáticas, Física e Inglés, así como la experimentación en otros proyectos. Se ofrecen materiales de ayuda para la experimentación, con numerosos ejemplos de aplicación didáctica en el aula, y se incluyen los materiales adaptados al aula preparados por el profesorado participante, que contiene diferente material de apoyo como hojas de trabajo.

Identitats ???queer', cossos i sexualitat en les narratives f??lmiques de la inf??ncia de Kore-eda Hirokazu

Resumen basado en el de la publicaci??n